Resources:
DHHR Office of Drug Control Policy:
https://dhhr.wv.gov/office-of-drug-control-policy
DHHR Office of Drug Control Policy Data Dashboard:
https://bit.ly/ODCPData
Rapid Access to Treatment: 1-844-HELP4WV or
https://www.help4wv.com/
Naloxone Access: https://bit.ly/ODPrevention
Urban Institute: https://urbn.is/3nmhl7J
Data Sources:
(1) West Virginia Board of Pharmacy
(2) West Virginia Department of Health and Human
Resources, Bureau for Behavioral Health
(3) West Virginia Department of Health and Human
Resources, Bureau for Medical Services
(4) West Virginia Alliance of Recovery Residences
(5) First Choice Services, Inc.
(6) West Virginia Department of Health and Human
Resources, Bureau for Public Health
(7) U.S. Census Bureau
(8) West Virginia Office of the Chief Medical Examiner
(9) Urban Institute
(--) Data unavailable at time of report.
Acronyms/Definitions
ED - Emergency Department Hospital Program – a comprehensive approach to SUD for individuals
who present to the ED can include screening, referral to treatment, providing naloxone, and Peer
Recovery Support Specialist consult.
HRP - Harm Reduction Program – refers to the use of practical strategies and ideas aimed at
reducing the negative consequences associated with drug use.
LEAD - Law Enforcement Assisted Diversion – a pre-booking diversion program aimed at
diverting low level criminal offenders away from incarceration and into treatment so that they can
receive definitive care for their underlying addiction.
MAT/MOUD – Medication–Assisted Treatment/Medications for Opioid Use Disorders – refers to
the three U.S. Food and Drug Administration approved medications used to treat opioid use
disorder: Methadone, Buprenorphine, and Naltrexone.
QRT – Quick Response Team - teams who contact people within 24-72 hours of an overdose to
connect them to treatment and other services.
START - Sobriety Treatment and Recovery Teams - an early intervention program for families
affected by substance use disorder
SUD – Substance Use Disorder - the recurrent use of alcohol or drugs causing clinically significant
impairment, including health problems, disability, and failure to meet major responsibilities at
work, school, or home.
As of January 2022
For more information, contact:
Matthew Q. Christiansen, MD, MPH
Director, DHHR Office of Drug Control Policy
Matthew.Q.Christiansen@wv.gov
https://dhhr.wv.gov/office-of-drug-control-policy
Scan for Free Naloxone:Get Help